Suzanne Reisz Porszasz, MD, Ph.D.

Scientific Advisor-USA Professor at Charles R. Drew University of Medicine and Science Department of Health and Life Sciences, USA.

She holds an Adjunct Assistant Professor position in the David Geffen School of Medicine at UCLA. She has worked and published articles on lung cancer in humans and various mammalians species’ muscle development.

Dr. George Yousef, MD Ph.D., FRCPC MSc

Dr. Yousef is Chief of Paediatric Laboratory Medicine and a Professor and Vice-Chair of the Department of Laboratory Medicine at the University of Toronto, Canada.

His research laboratory focuses on kidney and prostate cancer biomarkers using an integrated approach. He has over 250 published research papers and review articles and 15 book chapters. He is the editor of a book on “Molecular Pathology in Cancer.” He is a founding member of the International Scientific Committee of Kallikreins and the International Society of Enzymology. He is the editor-in-Chief of the Canadian Journal of Pathology. He is a member of the Royal Society of Canada, a founding member of the International Scientific Committee of Kallikreins.

Dr. Aditya Pai, Ph.D., MBA

Vice President, Corporate and Business Development, Canada

Dr. Pai has a broad network in the genomics industry and hospital of North America and has a role in the business activities of Enrich engaging KOLs. He is a top-ranked executive with twenty-three years of expertise in genomics, sequencing, artificial intelligence in healthcare and pharmaceuticals, clinical genetics, consulting and business development. He is an American Board of Genetic Counseling (ABGC) certified genetic counsellor who can successfully integrate scientific, clinical, business data, and scale businesses. Aditya has worked at IBM, Mount Sinai Hospital and Genuity Science in crucial leadership roles and is also a Faculty Instructor at Schulich School of Business, teaching an MBA course in the Health Industry Management program. linkedin.com/in/aditya-pai-aa34462

Dr. Amjadkhan A. Pathan, Ph.D. FCR, MBA (HHM)

Director of Asanaj Healthcare Education & Research Foundation Mumbai, India

Dr. Pathan has led 26 plus clinical trials ranging from Phase I to IV for projects related to AML and CML blood cancer in India.  

His initiative as a Chief of the Mega Cancer Screening and Treatment at a low-to-no cost was instrumental, and it helped 35,000 plus rural cancer patients across the state. The prestigious universities of India, Brazil, Turkey, Palestine, Iraq, and Nigeria have acknowledged his work on cancer awareness and awarded him honorary doctorate degrees. linkedin.com/in/dr-amjadkhan-pathan-3a47a726